These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38765012)

  • 1. KMT2D regulates activation, localization, and integrin expression by T-cells.
    Potter SJ; Zhang L; Kotliar M; Wu Y; Schafer C; Stefan K; Boukas L; Qu'd D; Bodamer O; Simpson BN; Barski A; Lindsley AW; Bjornsson HT
    Front Immunol; 2024; 15():1341745. PubMed ID: 38765012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome.
    Pilarowski GO; Cazares T; Zhang L; Benjamin JS; Liu K; Jagannathan S; Mousa N; Kasten J; Barski A; Lindsley AW; Bjornsson HT
    J Allergy Clin Immunol; 2020 Mar; 145(3):982-992. PubMed ID: 31816409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation.
    Wright A; Hall A; Daly T; Fontelonga T; Potter S; Schafer C; Lindsley A; Hung C; Bodamer O; Gussoni E
    FASEB J; 2021 Nov; 35(11):e21955. PubMed ID: 34613626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.
    Schwenty-Lara J; Nehl D; Borchers A
    Hum Mol Genet; 2020 Jan; 29(2):305-319. PubMed ID: 31813957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.
    Carosso GA; Boukas L; Augustin JJ; Nguyen HN; Winer BL; Cannon GH; Robertson JD; Zhang L; Hansen KD; Goff LA; Bjornsson HT
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31465303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
    Lindsley AW; Saal HM; Burrow TA; Hopkin RJ; Shchelochkov O; Khandelwal P; Xie C; Bleesing J; Filipovich L; Risma K; Assa'ad AH; Roehrs PA; Bernstein JA
    J Allergy Clin Immunol; 2016 Jan; 137(1):179-187.e10. PubMed ID: 26194542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology.
    Shpargel KB; Mangini CL; Xie G; Ge K; Magnuson T
    Development; 2020 Jul; 147(21):. PubMed ID: 32541010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Immune Profile in Individuals with Kabuki Syndrome.
    Comel M; Saad N; Sil D; Apparailly F; Willems M; Djouad F; Andrau JC; Lozano C; Genevieve D
    J Clin Immunol; 2024 Sep; 45(1):7. PubMed ID: 39264387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.
    Yap CS; Jamuar SS; Lai AHM; Tan ES; Ng I; Ting TW; Tan EC
    Gene; 2020 Mar; 731():144360. PubMed ID: 31935506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice.
    Fahrner JA; Lin WY; Riddle RC; Boukas L; DeLeon VB; Chopra S; Lad SE; Luperchio TR; Hansen KD; Bjornsson HT
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31557133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients.
    Micale L; Augello B; Maffeo C; Selicorni A; Zucchetti F; Fusco C; De Nittis P; Pellico MT; Mandriani B; Fischetto R; Boccone L; Silengo M; Biamino E; Perria C; Sotgiu S; Serra G; Lapi E; Neri M; Ferlini A; Cavaliere ML; Chiurazzi P; Monica MD; Scarano G; Faravelli F; Ferrari P; Mazzanti L; Pilotta A; Patricelli MG; Bedeschi MF; Benedicenti F; Prontera P; Toschi B; Salviati L; Melis D; Di Battista E; Vancini A; Garavelli L; Zelante L; Merla G
    Hum Mutat; 2014 Jul; 35(7):841-50. PubMed ID: 24633898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome.
    Tsang E; Han VX; Flutter C; Alshammery S; Keating BA; Williams T; Gloss BS; Graham ME; Aryamanesh N; Pang I; Wong M; Winlaw D; Cardamone M; Mohammad S; Gold W; Patel S; Dale RC
    EBioMedicine; 2024 Jun; 104():105156. PubMed ID: 38768529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the Oro-Dental and Mutational Spectra of Kabuki Syndrome and Expression of
    Porntaveetus T; Abid MF; Theerapanon T; Srichomthong C; Ohazama A; Kawasaki K; Kawasaki M; Suphapeetiporn K; Sharpe PT; Shotelersuk V
    Int J Biol Sci; 2018; 14(4):381-389. PubMed ID: 29725259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Macrophage activation syndrome in a patient with Kabuki syndrome.
    Zhang J; Kang Y; Xia Z; Chong Y; Long X; Shen M
    Front Immunol; 2024; 15():1412084. PubMed ID: 39139573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth deficiency in a mouse model of Kabuki syndrome 2 bears mechanistic similarities to Kabuki syndrome 1.
    Gao CW; Lin W; Riddle RC; Chopra S; Kim J; Boukas L; Hansen KD; Björnsson HT; Fahrner JA
    PLoS Genet; 2024 Jun; 20(6):e1011310. PubMed ID: 38857303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of methylation episignatures in
    Lee S; Ochoa E; Barwick K; Cif L; Rodger F; Docquier F; Pérez-Dueñas B; Clark G; Martin E; Banka S; Kurian MA; Maher ER
    Epigenomics; 2022 May; 14(9):537-547. PubMed ID: 35506254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic assessment and KMT2D mutation detection in Kabuki syndrome.
    Lin JL; Lee WI; Huang JL; Chen PK; Chan KC; Lo LJ; You YJ; Shih YF; Tseng TY; Wu MC
    Clin Genet; 2015 Sep; 88(3):255-60. PubMed ID: 25142838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular insights of KMT2D and clinical aspects of Kabuki syndrome type 1.
    Golden CS; Williams S; Serrano MA
    Birth Defects Res; 2023 Nov; 115(19):1809-1824. PubMed ID: 37158694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and behavioral characterization of a Kmt2d mouse mutant, a new model for Kabuki Syndrome.
    Yamamoto PK; de Souza TA; Antiorio ATFB; Zanatto DA; Garcia-Gomes MSA; Alexandre-Ribeiro SR; Oliveira NS; Menck CFM; Bernardi MM; Massironi SMG; Mori CMC
    Genes Brain Behav; 2019 Nov; 18(8):e12568. PubMed ID: 30891914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities.
    Sobreira N; Brucato M; Zhang L; Ladd-Acosta C; Ongaco C; Romm J; Doheny KF; Mingroni-Netto RC; Bertola D; Kim CA; Perez AB; Melaragno MI; Valle D; Meloni VA; Bjornsson HT
    Eur J Hum Genet; 2017 Dec; 25(12):1335-1344. PubMed ID: 29255178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.